No Data
No Data
No Data
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment With Nociscan AI Technology
Express News | Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
Express News | Aclarion Inc Files for Mixed Shelf of up to $50 Mln – SEC Filing
Aclarion Added to PRISM Emerging Medical Devices Index
No Data
No Data